84P MAINTENANCE LOW-DOSE GEMCITABINE VERSUS BEST SUPPORTIVE CARE IN ADVANCED AND METASTATIC NON-SMALL CELL LUNG CANCER: RANDOMIZED PHASE III TRIAL

Autor: Nagy, A.A., Fouad, E., Nasr, K., El-Ghazaly, H., Adel, A.
Zdroj: In Lung Cancer May 2013 80 Supplement 1:S37-S37
Databáze: ScienceDirect